Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Kindly MD, Inc. stock logo
KDLY
Kindly MD
$10.63
+5.4%
$12.00
$0.65
$34.77
$64.01MN/A2.29 million shs341,021 shs
LifeMD, Inc. stock logo
LFMD
LifeMD
$6.33
+0.6%
$10.79
$3.99
$15.84
$300.17M1.721.67 million shs1.57 million shs
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
$7.31
+3.7%
$6.73
$5.93
$9.81
$283.56M1.33176,765 shs353,081 shs
Exagen Inc. stock logo
XGN
Exagen
$10.10
+1.2%
$7.84
$2.38
$10.34
$222.20M1.61231,984 shs495,160 shs
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Kindly MD, Inc. stock logo
KDLY
Kindly MD
-4.99%-23.85%-7.85%-57.75%+483.24%
LifeMD, Inc. stock logo
LFMD
LifeMD
+1.62%-4.70%-39.29%-45.45%+18.68%
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
+2.77%+2.32%+8.46%+9.81%-1.40%
Exagen Inc. stock logo
XGN
Exagen
+1.42%+6.74%+43.80%+51.21%+225.08%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Kindly MD, Inc. stock logo
KDLY
Kindly MD
N/AN/AN/AN/AN/AN/AN/AN/A
LifeMD, Inc. stock logo
LFMD
LifeMD
2.7031 of 5 stars
3.52.00.00.02.91.70.6
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
2.1917 of 5 stars
0.03.00.00.02.83.31.3
Exagen Inc. stock logo
XGN
Exagen
3.5564 of 5 stars
2.51.00.04.52.52.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Kindly MD, Inc. stock logo
KDLY
Kindly MD
0.00
N/AN/AN/A
LifeMD, Inc. stock logo
LFMD
LifeMD
3.00
Buy$12.86101.52% Upside
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
0.00
N/AN/AN/A
Exagen Inc. stock logo
XGN
Exagen
3.00
Buy$11.2511.45% Upside

Current Analyst Ratings Breakdown

Latest KDLY, LFMD, VMD, and XGN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/7/2025
LifeMD, Inc. stock logo
LFMD
LifeMD
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$14.00 ➝ $13.00
8/6/2025
LifeMD, Inc. stock logo
LFMD
LifeMD
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$18.00 ➝ $14.00
8/6/2025
LifeMD, Inc. stock logo
LFMD
LifeMD
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$14.00 ➝ $12.00
7/30/2025
Exagen Inc. stock logo
XGN
Exagen
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$10.00
7/30/2025
Exagen Inc. stock logo
XGN
Exagen
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$8.00 ➝ $11.00
7/30/2025
Exagen Inc. stock logo
XGN
Exagen
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSector Weight ➝ Overweight$12.00
7/23/2025
Exagen Inc. stock logo
XGN
Exagen
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$12.00
7/14/2025
LifeMD, Inc. stock logo
LFMD
LifeMD
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$12.00 ➝ $14.00
7/10/2025
LifeMD, Inc. stock logo
LFMD
LifeMD
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$12.00 ➝ $18.00
6/18/2025
LifeMD, Inc. stock logo
LFMD
LifeMD
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$15.00 ➝ $18.00
(Data available from 8/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Kindly MD, Inc. stock logo
KDLY
Kindly MD
$2.47M25.91N/AN/AN/A
LifeMD, Inc. stock logo
LFMD
LifeMD
$212.45M1.42N/AN/A$0.01 per share638.00
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
$224.26M1.26$1.00 per share7.29$3.65 per share2.00
Exagen Inc. stock logo
XGN
Exagen
$55.64M3.99N/AN/A$0.96 per share10.51
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Kindly MD, Inc. stock logo
KDLY
Kindly MD
N/A-$0.77N/AN/AN/AN/AN/AN/A
LifeMD, Inc. stock logo
LFMD
LifeMD
-$18.88M-$0.21N/A53.17N/A-2.41%N/A-8.11%11/6/2025 (Estimated)
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
$11.27M$0.3421.44N/A5.80%10.38%7.88%11/5/2025 (Estimated)
Exagen Inc. stock logo
XGN
Exagen
-$15.11M-$0.89N/AN/AN/A-28.85%-130.38%-34.69%N/A

Latest KDLY, LFMD, VMD, and XGN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
$0.0850$0.08-$0.0050$0.08$63.50 million$63.06 million
7/29/2025Q2 2025
Exagen Inc. stock logo
XGN
Exagen
-$0.18-$0.18N/A-$0.21$16.25 million$17.20 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Kindly MD, Inc. stock logo
KDLY
Kindly MD
N/AN/AN/AN/AN/A
LifeMD, Inc. stock logo
LFMD
LifeMD
N/AN/AN/AN/AN/A
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
N/AN/AN/AN/AN/A
Exagen Inc. stock logo
XGN
Exagen
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Kindly MD, Inc. stock logo
KDLY
Kindly MD
N/A
5.43
5.42
LifeMD, Inc. stock logo
LFMD
LifeMD
9.21
0.77
0.72
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
0.02
1.48
1.37
Exagen Inc. stock logo
XGN
Exagen
1.06
4.95
4.95

Institutional Ownership

CompanyInstitutional Ownership
Kindly MD, Inc. stock logo
KDLY
Kindly MD
N/A
LifeMD, Inc. stock logo
LFMD
LifeMD
35.52%
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
74.24%
Exagen Inc. stock logo
XGN
Exagen
75.25%

Insider Ownership

CompanyInsider Ownership
Kindly MD, Inc. stock logo
KDLY
Kindly MD
50.50%
LifeMD, Inc. stock logo
LFMD
LifeMD
18.40%
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
20.00%
Exagen Inc. stock logo
XGN
Exagen
12.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Kindly MD, Inc. stock logo
KDLY
Kindly MD
N/A6.02 million2.96 millionN/A
LifeMD, Inc. stock logo
LFMD
LifeMD
23047.42 million38.69 millionOptionable
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
1,17938.79 million31.03 millionNot Optionable
Exagen Inc. stock logo
XGN
Exagen
22022.00 million19.23 millionOptionable

Recent News About These Companies

Short Interest in Exagen Inc. (NASDAQ:XGN) Expands By 52.8%
BTIG Sticks to Their Buy Rating for Exagen (XGN)
What is KeyCorp's Forecast for Exagen Q3 Earnings?
Exagen (XGN) Receives a Buy from Craig-Hallum
Exagen Inc. Reports Record Revenue Amidst Growth Challenges
Keybanc Upgrades Exagen (XGN)
Exagen Q2 Revenue Jumps 14 Percent

New MarketBeat Followers Over Time

Media Sentiment Over Time

Kindly MD stock logo

Kindly MD NASDAQ:KDLY

$10.63 +0.54 (+5.35%)
As of 08/21/2025

Kindly MD, Inc. provides healthcare services. Its services include medication management, behavioral healthcare and alternative treatments. The firm offers evaluation and management, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy. The company was founded by Timothy Pickett in December 2019 and is headquartered in Murray, UT.

LifeMD stock logo

LifeMD NASDAQ:LFMD

$6.33 +0.04 (+0.64%)
Closing price 04:00 PM Eastern
Extended Trading
$6.35 +0.02 (+0.25%)
As of 06:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

Viemed Healthcare stock logo

Viemed Healthcare NASDAQ:VMD

$7.31 +0.26 (+3.69%)
Closing price 04:00 PM Eastern
Extended Trading
$7.32 +0.01 (+0.07%)
As of 04:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

Exagen stock logo

Exagen NASDAQ:XGN

$10.10 +0.12 (+1.20%)
Closing price 04:00 PM Eastern
Extended Trading
$10.09 -0.01 (-0.15%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Exagen Inc. develops and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables differential diagnosis for patients presenting with symptoms indicative of various connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The company offers AVISE Lupus that measures activation of the complement system by quantifying the level of B-cell C4d and erythrocyte bound C4d in the patient's blood; and AVISE APS, which consists of a panel of autoantibody tests that aids in the diagnosis and management of APS. In addition, it provides AVISE Vasculitis AAV, which utilizes a testing panel of individual analytes to provide physicians with results in the assessment and monitoring of anti-neutrophil cytoplasmic antibody associated vasculitis; AVISE SLE Prognostic, a panel of autoantibodies for assessing the potential for complications affecting the kidney, brain, and cardiovascular system; and AVISE Anti-CarP test, which identifies RA patients with severe disease. Further, the company offers AVISE SLE Monitor, a biomarker blood test; AVISE MTX, a patented and validated blood test; and AVISE HCQ, a blood test to monitor levels of hydroxychloroquine. It has a research collaboration and license agreement with Allegheny Health Network (AHN) Research Institute to develop novel patented biomarkers. The company was formerly known as Exagen Diagnostics, Inc. and changed its name to Exagen Inc. in January 2019. Exagen Inc. was incorporated in 2002 and is headquartered in Vista, California.